Published on: Tuesday, May 11, 2021
By: AFP
Text Size:
The Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine is pictured at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada s most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (AFP/CARLOS OSORIO / POOL)
FRANKFURT: Covid jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year.
BioNTech to build vaccine plant in Singapore
4
published : 10 May 2021 at 14:20
4 FILE PHOTO: Empty vials of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are seen at The Michener Institute, in Toronto, Canada Jan 4, 2021. (Reuters)
Covid jab maker BioNTech said Monday it would build a southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year.
Construction of the site will start this year, and it could become operational by 2023, the German company said in a statement. With this planned mRNA production facility, we will increase our overall network capacity and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world, said BioNTech chief executive Ugur Sahin.
E-Mail
IMAGE: Senior author and Princess Margaret Scientist Dr. Marianne Koritzinsky s research reveals the potential of targeted therapies to exploit unique metabolic features of pancreatic cancer cells. view more
Credit: Visual Services, UHN
(Toronto, Friday, May 7, 2021) Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them.
Led by Princess Margaret Cancer Centre (PM) Scientist Dr. Marianne Koritzinsky, researchers showed that about half of patient-derived pancreatic cancer cell lines are highly dependent or addicted to the protein peroxiredoxin 4 (PRDX4), as a result of the altered metabolic state of the cancer cell.